BlackRock Health Sciences Trust II
NYSE: BMEZ · FINANCIAL SERVICES · ASSET MANAGEMENT
Updated 2026-06-05
BlackRock Health Sciences Trust II (BMEZ) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $113.72M | $113.23M | — | — | 99.57% |
| 2020 | $5.24M | $79.56M | 100.00% | 1.31% | 1,517.89% |
| 2021 | $59.66M | $59.12M | 10.73% | 0.09% | 99.09% |
| 2022 | $-25.97M | $-26.47M | 100.00% | -5.93% | 101.93% |
| 2023 | $8.19M | $20.02M | 352.41% | 103.30% | 244.30% |
| 2024 | $24.07M | $23.45M | 100.00% | 3.85% | 97.44% |
Frequently asked questions
How profitable is BMEZ?
In its most recent fiscal year, BMEZ ran a gross margin of 100.00%, an operating margin of 3.85%, and a net margin of 97.44%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does BMEZ generate?
BMEZ produced $65.52M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is BMEZ's balance sheet healthy?
BMEZ holds $71339.00 in cash and equivalents against — in long-term debt, on $768.57M of shareholder equity. That debt is best read against the cash flow the business throws off each year.